ClinicalTrials.govpublic full text
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
atopic dermatitis, eczema, tezepelumab, dermatology, dermatitis, inflammation, skin, moderate dermatitis, severe dermatitis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 910387
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.